Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol for ischemia-reperfusion injury in TKA
NCT01638624Phase 4Completed
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- Jun 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propofol in ischemia-reperfusion injury (IRI), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Started Jun 2012; status: completed.
02
Drugs
propofol
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01638624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638624.